Praj Industries Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/gb55j35b82chlz0rb30d36qn.pdf

Key Takeaways


The Margin Collapse: Execution, Not Input Costs

Raole: "I think to a great extent the worst is over."

GenX: The Pivot and the Payoff

Gaikwad: "We started with a segment which was called an ETCA segment... but as you know, that in the last two years, that segment has become a little subdued. And so we had to pivot to the other segments where we can get our customer interactions going."

Ethanol Blending: The Policy Inflection

Gaikwad: "The current West Asia situation has once again highlighted the need for energy security for every nation. This will give further impetus to the production and usage of biofuels across all agri-rich countries."

New Technology Bets: Bio-IBA, SAF, and CBG

Gaikwad: "As we know, the volume requirement for diesel blending is much bigger than petrol. The use of bio-IBA in diesel blending is going to be a significant step in our nation's biofuels journey."

Order Book and Demand Visibility


Guidance & Commitments

CommitmentSpecificsTimeline
Data center cooling orderFirst modular cooling order for international data centers, value ₹50–150 crQ1 FY27
Bio-IBA first orderFirst commercial order for bio-isobutanol technologyCurrent quarter of FY27
GenX capacity utilizationOrders to be booked, then converted to revenue, with break-even as the targetNext 2–3 quarters for order booking
Deferred engineering ordersEngineering opportunities deferred in Q4 FY26 to convert into ordersFY27
SAF blending mandatesDraft policy ready, mandates expected2027
E85/E100 retail outlets150 outlets across four cities, scaling to 500 then 5,000150 within 1 month; 500 within 6–12 months; 5,000 within 24 months
Flex-fuel vehicle launchesMultiple OEMs launching flex-fuel and E100 vehiclesStarting June
Ethanol blending mandate increaseNew mandates beyond E20 expected, timing uncertain but believed within one yearNot longer than one year
Margin recoveryManagement states "the worst is over" on marginsFY27

Key Metrics

MetricQ4 FY26
Consolidated income from operations₹844.5 cr, compared to ₹859.8 cr in Q4 FY25
Profit before tax (before exceptional item)₹1.54 cr, compared to ₹58.25 cr in Q4 FY25
Profit after tax₹11.6 cr, compared to ₹39.8 cr in Q4 FY25
Full-year FY26 income from operations₹3,167.9 cr, compared to ₹3,228 cr in FY25
Full-year FY26 PAT₹23.8 cr, compared to ₹28.9 cr in FY25
Export revenue share36% of FY26 total revenue
Revenue mix67% bioenergy, 22% engineering, 11% PHS
Order intake₹658 cr, 79% domestic, 86% from bioenergy
Order backlog₹4,305 cr, 66% domestic, 78% from bioenergy
Cash in hand₹612 cr as on 31st March 2026
Proposed final dividend₹3.6 per equity share, 180% of face value of ₹2
Consolidated raw material cost increaseUp 3% in Q4; other expenses down 2%, net additional impact of 1-1.5%
Deferred inquiry basket~₹300+ cr not finalized due to raw material price uncertainty
GenX fixed overhead run rate~₹10 crores per month
R&D spend in FY26~₹65-66 cr total, split into ~₹20 cr CapEx and ~₹45-46 cr OpEx
Clients approved Mangalore facility12-13, up from ~9 at end of Q3